BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21266176)

  • 1. Linker length dependent binding of a focal adhesion kinase derived peptide to the Src SH3-SH2 domains.
    Lindfors HE; Venkata BS; Drijfhout JW; Ubbink M
    FEBS Lett; 2011 Feb; 585(4):601-5. PubMed ID: 21266176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Src SH2 domain interacts dynamically with the focal adhesion kinase binding site as demonstrated by paramagnetic NMR spectroscopy.
    Lindfors HE; Drijfhout JW; Ubbink M
    IUBMB Life; 2012 Jun; 64(6):538-44. PubMed ID: 22550026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT
    Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.
    Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H
    Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
    Liu J; Li M; Ran X; Fan JS; Song J
    Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteronuclear NMR studies of the combined Src homology domains 2 and 3 of pp60 c-Src: effects of phosphopeptide binding.
    Tessari M; Gentile LN; Taylor SJ; Shalloway DI; Nicholson LK; Vuister GW
    Biochemistry; 1997 Nov; 36(47):14561-71. PubMed ID: 9398174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain.
    Ye G; Ayrapetov M; Nam NH; Sun G; Parang K
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4994-7. PubMed ID: 16169725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies.
    Rubini C; Ruzza P; Spaller MR; Siligardi G; Hussain R; Udugamasooriya DG; Bellanda M; Mammi S; Borgogno A; Calderan A; Cesaro L; Brunati AM; Donella-Deana A
    Biopolymers; 2010; 94(3):298-306. PubMed ID: 19921743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of affinities for lck SH2 binding peptides using a sensitive fluorescence assay: comparison between the pYEEIP and pYQPQP consensus sequences reveals context-dependent binding specificity.
    Cousins-Wasti RC; Ingraham RH; Morelock MM; Grygon CA
    Biochemistry; 1996 Dec; 35(51):16746-52. PubMed ID: 8988011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomic resolution structures of the c-Src SH3 domain in complex with two high-affinity peptides from classes I and II.
    Bacarizo J; Camara-Artigas A
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):756-66. PubMed ID: 23633584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the Src homology 3-Src homology 2 interface in the regulation of Src kinases.
    Arold ST; Ulmer TS; Mulhern TD; Werner JM; Ladbury JE; Campbell ID; Noble ME
    J Biol Chem; 2001 May; 276(20):17199-205. PubMed ID: 11278857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Energetics of Src homology domain interactions in receptor tyrosine kinase-mediated signaling.
    Ladbury JE; Arold ST
    Methods Enzymol; 2011; 488():147-83. PubMed ID: 21195228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ; Atwell SK; Shoelson SE; Harrison SC
    Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Focal Adhesion Kinase-Derived Peptide Binds the Src SH3 Domain in Two Orientations, As Demonstrated Using Paramagnetic Nuclear Magnetic Resonance.
    Somireddy Venkata B; Keizers PH; Drijfhout JW; Ubbink M
    Biochemistry; 2016 Jan; 55(1):29-37. PubMed ID: 26645346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
    Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.